Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters
Endocrine Journal · 2026 · 73 (11) · 1261-1269
DOI: 10.1507/endocrj.ej26-0246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Journal, 2026. Verfasst von Hiroya Kitsunai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism, and Rheumatology, Department of Internal Medicine, Asahikawa Medical University, Hokkaido 078-8510, Japan. Hauptthemen laut MEDLINE: Tirzepatide, Diabetes Mellitus, Type 2, Hypoglycemia, Weight Loss. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Metabolism, and Rheumatology, Department of Internal Medicine, Asahikawa Medical University, Hokkaido 078-8510, Japan.
- Sapporo Diabetes and Thyroid Clinic, Hokkaido 060-0807, Japan.
- Kurihara Clinic, Hokkaido 004-0053, Japan.
- Department of Diabetology and Endocrinology, Japanese Red Cross Asahikawa Hospital, Hokkaido 070-0061, Japan.
- Department of Diabetology and Endocrinology, Asahikawa City Hospital, Hokkaido 070-8610, Japan.
- Department of Metabolism and Endocrinology, Asahikawa-Kosei General Hospital, Hokkaido 078-8211, Japan.
Zitieren
APA
Kitsunai, H., Maruyama, F., Miyano, Y., Abe, T., Kurihara, H., Tsuji, K., Abiko, A., Miyamoto, Y., Homma, R., Nakamura, A., Nomoto, H., & Hokkaido-TZP Study Group (2026). Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters. Endocrine Journal, 73(11), 1261-1269. https://doi.org/10.1507/endocrj.ej26-0246
Vancouver
Kitsunai H, Maruyama F, Miyano Y, Abe T, Kurihara H, Tsuji K, et al. Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters. Endocrine Journal. 2026;73(11):1261-1269. doi:10.1507/endocrj.ej26-0246
BibTeX
@article{Kitsunai2026,
author = {Kitsunai, Hiroya and Maruyama, Fumika and Miyano, Yukie and Abe, Tomoe and Kurihara, Hiroyoshi and Tsuji, Ken and Abiko, Atsuko and Miyamoto, Yoshihiro and Homma, Reiko and Nakamura, Akinobu and Nomoto, Hiroshi and Hokkaido-TZP Study Group, Hokkaido-TZP Study Group},
title = {Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters},
journal = {Endocrine Journal},
year = {2026},
volume = {73},
number = {11},
pages = {1261--1269},
doi = {10.1507/endocrj.ej26-0246}
}
EUVIMED